Prologue Medicines

Cambridge, United States

Prologue Medicines creates transformative medicines by systematically discovering and evaluating viral proteins and their unique features.

$50.0M raised

May 2024

Series A

Health Care Medical Pharmaceutical

Top Investors

Flagship Pioneering

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Prologue Medicines

How much funding has Prologue Medicines raised?

Prologue Medicines has raised $50.0M in total funding. The most recent round was Series A. The last funding was announced in May 2024.

Who are Prologue Medicines's investors?

Prologue Medicines's investors include Flagship Pioneering.

Where is Prologue Medicines headquartered?

Prologue Medicines is headquartered in Cambridge, United States.

What does Prologue Medicines do?

Prologue Medicines creates transformative medicines by systematically discovering and evaluating viral proteins and their unique features.

What stage is Prologue Medicines at?

Prologue Medicines is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 7, 2024.

MLA

"Prologue Medicines — Funding & Investors." VCBacked, May 7, 2024, https://www.vcbacked.co/company/prologue-medicines. Accessed July 3, 2026.

APA

VCBacked. (2024). Prologue Medicines — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/prologue-medicines

Wikipedia (cite web)

{{cite web |title=Prologue Medicines — Funding & Investors |url=https://www.vcbacked.co/company/prologue-medicines |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 7, 2024.

Similar Companies in Health Care

View all

Oryl Photonics

Lausanne

Allterum Therapeutics

Circl Brain Health Metrics

Victoria$354K

YLAH

Bern$589K